会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • N-substituted cycloalkyl and polycycloalkyl
polyhydro-.beta.-carboline-phenylalanine- and phenethylamine derivatives
    • N-取代的环己基和多环烷基多羟基 - (βA)-CARBOLINE-苯乙烯胺和苯乙烯衍生物
    • US5244905A
    • 1993-09-14
    • US726651
    • 1991-07-12
    • David C. HorwellEdward RobertsUwe Trostmann
    • David C. HorwellEdward RobertsUwe Trostmann
    • C07D471/04
    • C07D471/04
    • Novel substituted polyhydro-.beta.-carboline derivatives useful as agents in the treatment of obesity, hypersecretion of gastric acid in the gut, gastrin-dependent tumors, or as antipsychotic agents are disclosed. Further the compounds are antianxiety agents and antiulcer agents. Further, the compounds are useful for treating and/or preventing panic attacks. They are agents useful for preventing the response to withdrawal from chronic treatment with or use of nicotine, caffeine, diazepam, alcohol, cocaine or opioids. Also disclosed are pharmaceutical compositions and methods of treatment using the compounds as well as processes for preparing them and novel intermediates useful in their preparation. An additional feature of the invention is the use of the subject compounds in diagnostic compositions.
    • 新型取代的多羟基-β-咔啉衍生物可用作治疗肥胖症,胃肠胃分泌过多,胃泌素依赖性肿瘤或抗精神病药物。 此外,化合物是抗焦虑剂和抗溃疡剂。 此外,这些化合物可用于治疗和/或预防恐慌发作。 它们是可用于防止慢性治疗或使用尼古丁,咖啡因,地西泮,酒精,可卡因或阿片样物质的戒断反应的药剂。 还公开了使用该化合物的药物组合物和治疗方法以及其制备方法和可用于其制备的新型中间体。 本发明的另一个特征是本发明化合物在诊断组合物中的用途。